This Promising GLP-1 Drug Could Renew Novo Nordisk Hope
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
Wondering what percentage of your income to invest for retirement? This guide helps you determine the right amount to secure your financial future.
16,091 articlesNovo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
A Friday executive order on mortgages is reshaping regulatory expectations, prioritizing smaller lenders while drawin...
January new-home activity sank 17.6% to 587,000 SAAR, with prices sliding and winter weather cited as a key acceleran...
Geopolitics and energy markets collide as Iran-related headlines drive price moves. Investors are reassessing risk, h...
As 2026 unfolds, oil markets face three potential paths. This guide breaks down the scenarios and offers concrete ste...
Investors are watching the AI data center crowd closely. This guide weighs CoreWeave against Applied Digital, offerin...
Both ServiceNow and Salesforce fell roughly 5% on the latest trading session as AI licensing concerns rattled investo...
XRP trades near $1.50 as XRPL tokenization accelerates. Analysts weigh whether the token could reach $10 if XRP becom...
Microsoft is staring down a tough start to the year. Is the slide a red flag or a rare chance to buy a tech titan wit...
A notable pullback in semiconductor stocks has sharpened the buying case for a diversified chip ETF. As earnings beat...
The March 2026 PCE data show the fed's favored inflation gauge staying elevated, signaling limited relief for househo...
Timken stands at a pivotal moment as it reports Q1 2026 earnings. This guide breaks down the business mix, growth dri...